Takara Bio Inc., a biotechnology company in Otsu, Japan, has developed a system which allows for mass production of a wide variety of DNA (deoxyribonucleic acid) fragments needed to make DNA ...

The poor suitability of standard hemagglutination-based assay techniques for large-scale automated screening of red blood cell antigens severely limits the ability of blood banks to supply extensively ...

Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...